A new study from Cleveland Clinic researchers evaluated the perceived health-related quality-of-life benefits of CI among normally-developing children and NCNIDD children.
A study combining genetic data and statistical modeling has generated some of the first epidemiologic estimates for neurodevelopment disorders caused by de novo variants. It promises much-needed guidance on priorities around these rare diseases.
High rates of neurodevelopmental disability are the one downside of improved survival among kids with congenital heart disease. Here’s why Cleveland Clinic created a Neurocardiac Clinic for these patients’ unique needs.
Considering the variety and complexity of symptoms involved in the pediatric neurodevelopmental disorder known as CDKL5-related disease, a multidisciplinary approach to medical care is important. Cleveland Clinic Children’s opened the country’s third CDKL5 center of excellence in 2014.